The Role of Monocyte Percentage in Osteoporosis in Male Rheumatic Diseases
- PMID: 28901203
- PMCID: PMC5675259
- DOI: 10.1177/1557988317721642
The Role of Monocyte Percentage in Osteoporosis in Male Rheumatic Diseases
Abstract
Osteoporosis is easily overlooked in male patients, especially in the field of rheumatic diseases mostly prevalent with female patients, and its link to pathogenesis is still lacking. Attenuated monocyte apoptosis from a transcriptome-wide expression study illustrates the role of monocytes in osteoporosis. This study tested the hypothesis that the monocyte percentage among leukocytes could be a biomarker of osteoporosis in rheumatic diseases. Eighty-seven males with rheumatic diseases were evaluated in rheumatology outpatient clinics for bone mineral density (BMD) and surrogate markers, such as routine peripheral blood parameters and autoantibodies. From the total number of 87 patients included in this study, only 15 met the criteria for diagnosis of osteoporosis. Both age and monocyte percentage remained independently associated with the presence of osteoporosis. Steroid dose (equivalent prednisolone dose) was negatively associated with BMD of the hip area and platelet counts were negatively associated with BMD and T score of the spine area. Besides age, monocyte percentage meets the major requirements for osteoporosis in male rheumatic diseases. A higher monocyte percentage in male rheumatic disease patients, aged over 50 years in this study, and BMD study should be considered in order to reduce the risk of osteoporosis-related fractures.
Keywords: male; monocyte; osteoporosis; rheumatic diseases.
Conflict of interest statement
Figures
Similar articles
-
Correlation of different bone markers with bone density in patients with rheumatic diseases on glucocorticoid therapy.Rheumatol Int. 2006 Feb;26(4):331-6. doi: 10.1007/s00296-005-0608-8. Epub 2005 May 11. Rheumatol Int. 2006. PMID: 15887044
-
Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases.Clin Exp Rheumatol. 2003 Jan-Feb;21(1):19-26. Clin Exp Rheumatol. 2003. PMID: 12673885 Clinical Trial.
-
Predictors of bone mineral density and osteoporosis in patients attending a rheumatology outpatient clinic.Rheumatol Int. 2003 Mar;23(2):67-9. doi: 10.1007/s00296-002-0250-7. Epub 2002 Oct 22. Rheumatol Int. 2003. PMID: 12634938
-
Estimating prevalence of osteoporosis: examples from industrialized countries.Arch Osteoporos. 2014;9:182. doi: 10.1007/s11657-014-0182-3. Epub 2014 May 16. Arch Osteoporos. 2014. PMID: 24847682 Review.
-
[Osteoporosis in the aged male].Presse Med. 2002 Nov 23;31(37 Pt 1):1760-9. Presse Med. 2002. PMID: 12489321 Review. French.
Cited by
-
A correlative studies between osteoporosis and blood cell composition: Implications for auxiliary diagnosis of osteoporosis.Medicine (Baltimore). 2020 Jun 26;99(26):e20864. doi: 10.1097/MD.0000000000020864. Medicine (Baltimore). 2020. PMID: 32590789 Free PMC article.
-
Non-diabetic elderly populations: the MHR as a protective factor against bone abnormalities.Front Endocrinol (Lausanne). 2024 Jun 7;15:1408467. doi: 10.3389/fendo.2024.1408467. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38911035 Free PMC article.
-
Integrative Analyses of Genes Associated With Osteoporosis in CD16+ Monocyte.Front Endocrinol (Lausanne). 2021 Jan 21;11:581878. doi: 10.3389/fendo.2020.581878. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33551990 Free PMC article.
-
Causal relationship between immune cells and osteoporosis based on genetic prediction: a bidirectional two-sample mediated Mendelian randomization analysis.Sci Rep. 2025 Jun 4;15(1):19524. doi: 10.1038/s41598-025-95740-1. Sci Rep. 2025. PMID: 40467777 Free PMC article.
References
-
- Amendola L., Gasbarrini A., Fosco M., Simoes C. E., Terzi S., De Iure F., Boriani S. (2011). Fenestrated pedicle screws for cement-augmented purchase in patients with bone softening: A review of 21 cases. Journal of Orthopaedics and Traumatology, 12(4), 193–199. doi:10.1007/s10195-011-0164-9 - DOI - PMC - PubMed
-
- Bieglmayer C., Dimai H. P., Gasser R. W., Kudlacek S., Obermayer-Pietsch B., Woloszczuk W., . . . Griesmacher A. (2012). Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: A consensus advice from an Austrian working group. Wiener Medizinische Wochenschrift, 162(21–22), 464–477. doi:10.1007/s10354-012-0133-9 - DOI - PubMed
-
- Bisbocci D., Gallo V., Damiano P., Sidoli L., Cantoni R., Aimo G., . . . Chiandussi L. (1996). Spontaneous release of interleukin 1 beta from human blood monocytes in thyrotoxic osteodystrophy. Journal of Endocrinological Investigation, 19(8), 511–515. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous